NTNU Klinisk og Molekylær Medisin
@ntnuikom
Ved IKOM skjer basal-, klinisk-, og translasjonsforskning innen brede medisinske fagområder. Undervisning og forskning for bedre helse.
ID: 1252888973246173184
http://ntnu.no/ikom 22-04-2020 09:16:53
361 Tweet
330 Followers
229 Following
Professor Marit Otterlei ved NTNU Klinisk og Molekylær Medisin har laget en helt ny type kreftmedisin. Ingen lignende medisiner har kommet så langt i utviklingen på verdensbasis. gemini.no/2023/03/dodssy…
The birth prevalence of dyskinetic CP in Norway was low and decreased significantly from 1996 to 2015. It suggests that general improvements in antenatal, obstetric, and neonatal care may prevent some cases of dyskinetic CP onlinelibrary.wiley.com/doi/full/10.11… NTNU Klinisk og Molekylær Medisin
We have vacancies for two PhD candidates in the AICAN group. The candidates will develop and validate machine learning techniques for automatic assessment of digital breast and lung cancer tissue sections. jobbnorge.no/en/available-j… NTNU Klinisk og Molekylær Medisin ntnu.edu/ikom/aican#/vi… Ingerid Reinertsen
Svært interessant sak i A-magasinet om hvordan Magnar Bjørås ved NTNU Klinisk og Molekylær Medisin gir Julian og barn som ham et håp: aftenposten.no/amagasinet/i/B…
Finally, our story on #endoglin and #BMP9 signaling with the group of Wei Li is out. This is also the first 1st author paper of PhD student Clara Andersson-Rusch NTNU Klinisk og Molekylær Medisin St. Olavs hospital NTNU Faculty of Natural Sciences
Mødre som føder svært premature barn, har et sterkt behov for å få bekreftet at barnet er livskraftig. Det oppnås best gjennom tidlig hudkontakt. sykepleien.no/fag/2023/04/ti… NTNU Klinisk og Molekylær Medisin Tidsskriftet Sykepleien
We have a vacancy for a PhD candidate in #SpatialTranscriptomics NTNU Klinisk og Molekylær Medisin on the project Identifying small-cell lung cancer patients responding to immune checkpoint inhibitors jobbnorge.no/en/available-j… #SmallCellLungCancer
We wrote a preview on the latest article by Lehtinen Lab on choroid plexus targeted therapies against post-hemorrhagic hydrocephalus with Inyoung Jeong (Jung). It is out now available in Neuron. doi.org/10.1016/j.neur…
We have a vacancy for one PhD candidate in #bioinformatics at NTNU Klinisk og Molekylær Medisin within the field of computational precision medicine, and with a focus on multi-omics data integration for cancer signalling modelling jobbnorge.no/en/available-j… Åsmund Flobak
Are you interested in joining our research group NTNU Klinisk og Molekylær Medisin in Trondheim, and work and work on tomorrow's biomarkers for cancer therapy? We have a PhD just opened in bioinformatics on scRNA on cancer cells and patient tumour derived spheroids. jobbnorge.no/en/available-j…
Exciting opportunity to conduct cutting-edge research in Tuberculosis drug discovery in an Academia-Industry collaboration led by Marte Dragset #CEMIR NTNU Klinisk og Molekylær Medisin linkedin.com/feed/update/ur…
One day conference on 'a healthy future' ntnu.edu/health/confere… from NTNU Health - I'm looking forward to the talks and not least Precision Medicine Frontiers with Kjetil Tasken Stine Korreman (she/her) and Mattijs Elschot!! NTNU medisin og helse NTNU Klinisk og Molekylær Medisin
Are you interested in a PhD position on functional preicision medicine for colon cancer? See our PhD application: jobbnorge.no/en/available-j… Funded @Kreftforeningen Norges forskningsråd via MATRIX. NTNU Åslaug Helland Kjetil Tasken Hege Russnes Eva Hofsli The Society for Functional Precision Medicine St. Olavs hospital
We have a vacancy for a PhD candidate who will be part of designing and running a clinical trial on #PrecisionMedicine, where we make use of #ColonCancer lab cultivated cells for therapy selection jobbnorge.no/en/available-j… NTNU Klinisk og Molekylær Medisin Åsmund Flobak @Kreftforeningen